JPH0376304B2 - - Google Patents
Info
- Publication number
- JPH0376304B2 JPH0376304B2 JP15420286A JP15420286A JPH0376304B2 JP H0376304 B2 JPH0376304 B2 JP H0376304B2 JP 15420286 A JP15420286 A JP 15420286A JP 15420286 A JP15420286 A JP 15420286A JP H0376304 B2 JPH0376304 B2 JP H0376304B2
- Authority
- JP
- Japan
- Prior art keywords
- tetrahydroxyvitamin
- activity
- dihydroxyvitamin
- lactone
- intestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QDZSTMXTBPCCGE-CJJVECAQSA-N (2r,4s,6r)-6-[(1r,3as,4e,7ar)-4-[(2z)-2-[(3s,5r)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-1-yl]-2-methylheptane-1,2,4-triol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](C[C@H](O)C[C@@](C)(O)CO)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C QDZSTMXTBPCCGE-CJJVECAQSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 18
- 229910052791 calcium Inorganic materials 0.000 description 18
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 10
- 239000011612 calcitriol Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 210000004347 intestinal mucosa Anatomy 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- -1 lithium aluminum hydride Chemical compound 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 238000002211 ultraviolet spectrum Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15420286A JPS6310757A (ja) | 1986-07-02 | 1986-07-02 | １α，２３，２５，２６−テトラヒドロキシビタミンＤ↓３ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15420286A JPS6310757A (ja) | 1986-07-02 | 1986-07-02 | １α，２３，２５，２６−テトラヒドロキシビタミンＤ↓３ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6310757A JPS6310757A (ja) | 1988-01-18 |
| JPH0376304B2 true JPH0376304B2 (enExample) | 1991-12-05 |
Family
ID=15579072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15420286A Granted JPS6310757A (ja) | 1986-07-02 | 1986-07-02 | １α，２３，２５，２６−テトラヒドロキシビタミンＤ↓３ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6310757A (enExample) |
-
1986
- 1986-07-02 JP JP15420286A patent/JPS6310757A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6310757A (ja) | 1988-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5552392A (en) | Method of treating hypoparathyroidism with (20S) vitamin D compounds | |
| WO1983000335A1 (en) | 26,26,26,27,27,27-HEXAFLUORO-1'alpha',25-DIHYDROXYCHOLECALCIFEROL AND PROCESS FOR PREPARING SAME | |
| HU211025B (en) | Process for producing novel vitamin d analogues and pharmaceutical compositions containing the same | |
| JPH0725730B2 (ja) | 細胞分化の誘発に有効な化合物の製法 | |
| AU568549B2 (en) | Process for the preparation of 1a, 25-dihydroxylated vitamin d2 and related compounds | |
| JPH11507649A (ja) | ２５位の炭素に置換基を有する新規なビタミンｄ誘導体、その製造方法、中間生成物及び薬剤の製造のためのその使用 | |
| JPH0692989A (ja) | Δ２２−コレスタ−５，７，２２−トリエン−１α，３β，２４−トリオール化合物 | |
| IE50815B1 (en) | 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol | |
| US4201881A (en) | 24,24-Difluoro-1α,25-dihydroxycholecalciferol | |
| US4505906A (en) | Hydroxyvitamin D2 isomers | |
| US4481198A (en) | Vitamin D metabolism inhibitor | |
| US4617297A (en) | Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol | |
| HUP9904333A2 (hu) | D-vitamin-analógok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| IE49532B1 (en) | 24,24-difluoro-25-hydroxycholecalciferol | |
| IE67953B1 (en) | Side Chain Unsaturated 1alpha-Hydroxyvitamin D Homologs | |
| EP0015122A1 (en) | New 25-hydroxy-24-oxocholestane derivatives and preparation thereof | |
| GB2111504A (en) | 23-dehydro-25-hydroxyvitamin d3 | |
| US4634692A (en) | Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol | |
| JPH05178887A (ja) | １α，３β，２５−トリヒドロキシ−２４−ホモコレスタ−５，７−ジエン類似体 | |
| JPH0364498B2 (enExample) | ||
| NL8520009A (nl) | 1alfa.25-dihydroxy-22z-dehydrovitamine d verbinding. | |
| JPS6310757A (ja) | １α，２３，２５，２６−テトラヒドロキシビタミンＤ↓３ | |
| FR2560597A1 (fr) | Produits analogues de la 1a-hydroxyvitamine d2, leur procede de preparation et compositions pharmaceutiques les renfermant | |
| JPH0495082A (ja) | １α，２５―ジヒドロキシビタミンＤ↓３―２６，２３―ラクトール | |
| JPS6140231B2 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |